Literature DB >> 27801510

MHC-Peptide Tetramers to Visualize Antigen-Specific T Cells.

John D Altman1, Mark M Davis2.   

Abstract

Mature T lymphocytes of the CD8 or CD4 classes bear αβ T cell receptors (TCR) that are specific for a molecular complex consisting of a major histocompatibility complex class I or II (MHC class I or II) molecule bound to a unique self or foreign peptide. Until recently, methods for monitoring antigen-specific T cell immune responses were restricted primarily to functional assays based on limiting dilution analysis, because the lack of specific molecular reagents to identify clonal T cells obviated approaches to identify and enumerate specific T cells. Development of efficient methods to express and refold MHC class I molecules with synthetic peptides coincided with identification of specific protein sequences that provide the substrate for enzymatic biotinylation. This combination has led to the development of a straightforward method for generating synthetic TCR ligands, making them tetravalent to provide increased avidity, and labeling them through a streptavidin moiety with useful fluorescent tags such as allophycocyanin or R-phycoerythrin. This unit describes the preparation of MHC class I/peptide tetramers in detail, including bacterial expression and refolding of the MHC class I light chain, β2-microglobulin (β2m), as well as the formation of a complex consisting of the MHC class I heavy chain of interest, β2m, and a chosen peptide. © 2016 by John Wiley & Sons, Inc.
Copyright © 2016 John Wiley & Sons, Inc.

Entities:  

Keywords:  MHC tetramers; T cells; flow cytometry

Mesh:

Substances:

Year:  2016        PMID: 27801510     DOI: 10.1002/cpim.14

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  14 in total

1.  Definition of Naturally Processed Peptides Reveals Convergent Presentation of Autoantigenic Topoisomerase I Epitopes in Scleroderma.

Authors:  Eleni Tiniakou; Andrea Fava; Zsuzsanna H McMahan; Tara Guhr; Robert N O'Meally; Ami A Shah; Fredrick M Wigley; Robert N Cole; Francesco Boin; Erika Darrah
Journal:  Arthritis Rheumatol       Date:  2020-06-26       Impact factor: 10.995

2.  Peptide:MHCII Tetramer-Based Cell Enrichment for the Study of Epitope-Specific CD4+ T Cells.

Authors:  Dmitri I Kotov; Marc K Jenkins
Journal:  Curr Protoc Immunol       Date:  2019-04-29

3.  Mouse PVRIG Has CD8+ T Cell-Specific Coinhibitory Functions and Dampens Antitumor Immunity.

Authors:  Benjamin Murter; Xiaoyu Pan; Eran Ophir; Zoya Alteber; Meir Azulay; Rupashree Sen; Ofer Levy; Liat Dassa; Ilan Vaknin; Tal Fridman-Kfir; Ran Salomon; Achinoam Ravet; Ada Tam; Doron Levin; Yakir Vaknin; Evgeny Tatirovsky; Arthur Machlenkin; Drew Pardoll; Sudipto Ganguly
Journal:  Cancer Immunol Res       Date:  2019-01-18       Impact factor: 11.151

4.  Expression and characterization of soluble epitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines.

Authors:  Amanda L Wooster; Trevor S Anderson; Devin B Lowe
Journal:  J Immunol Methods       Date:  2018-10-19       Impact factor: 2.303

5.  Targeting a neoantigen derived from a common TP53 mutation.

Authors:  Emily Han-Chung Hsiue; Katharine M Wright; Jacqueline Douglass; Michael S Hwang; Brian J Mog; Alexander H Pearlman; Suman Paul; Sarah R DiNapoli; Maximilian F Konig; Qing Wang; Annika Schaefer; Michelle S Miller; Andrew D Skora; P Aitana Azurmendi; Michael B Murphy; Qiang Liu; Evangeline Watson; Yana Li; Drew M Pardoll; Chetan Bettegowda; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Sandra B Gabelli; Shibin Zhou
Journal:  Science       Date:  2021-03-01       Impact factor: 47.728

6.  Production of Class II MHC Proteins in Lentiviral Vector-Transduced HEK-293T Cells for Tetramer Staining Reagents.

Authors:  Richard A Willis; Vasanthi Ramachandiran; John C Shires; Ge Bai; Kelly Jeter; Donielle L Bell; Lixia Han; Tamara Kazarian; Kyla C Ugwu; Oskar Laur; Susana Contreras-Alcantara; Dale L Long; John D Altman
Journal:  Curr Protoc       Date:  2021-02

7.  Minimal Information about MHC Multimers (MIAMM).

Authors:  Randi Vita; Apurva Mody; James A Overton; Soren Buus; Stephen T Haley; Alessandro Sette; Vamsee Mallajosyula; Mark M Davis; Dale L Long; Richard A Willis; Bjoern Peters; John D Altman
Journal:  J Immunol       Date:  2022-02-01       Impact factor: 5.426

8.  Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.

Authors:  Shira Weingarten-Gabbay; Susan Klaeger; Siranush Sarkizova; Leah R Pearlman; Da-Yuan Chen; Kathleen M E Gallagher; Matthew R Bauer; Hannah B Taylor; W Augustine Dunn; Christina Tarr; John Sidney; Suzanna Rachimi; Hasahn L Conway; Katelin Katsis; Yuntong Wang; Del Leistritz-Edwards; Melissa R Durkin; Christopher H Tomkins-Tinch; Yaara Finkel; Aharon Nachshon; Matteo Gentili; Keith D Rivera; Isabel P Carulli; Vipheaviny A Chea; Abishek Chandrashekar; Cansu Cimen Bozkus; Mary Carrington; Nina Bhardwaj; Dan H Barouch; Alessandro Sette; Marcela V Maus; Charles M Rice; Karl R Clauser; Derin B Keskin; Daniel C Pregibon; Nir Hacohen; Steven A Carr; Jennifer G Abelin; Mohsan Saeed; Pardis C Sabeti
Journal:  Cell       Date:  2021-06-03       Impact factor: 66.850

9.  In Vitro Assays to Study PD-1 Biology in Human T Cells.

Authors:  Anna S Tocheva; Shalom Lerrer; Adam Mor
Journal:  Curr Protoc Immunol       Date:  2020-09

Review 10.  CD1: From Molecules to Diseases.

Authors:  D Branch Moody; Sara Suliman
Journal:  F1000Res       Date:  2017-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.